Suchergebnisse - "Breccia, Massimo"

PubPharm (80)

1

Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib : Long-term 9-year follow-up of 134 patients

enthalten in: American journal of hematology | 2015

von Breccia, M. | Latagliata, R. | Molica, M. | +5

2

Incidence of persistent/late chronic anemia in newly diagnosed patients with chronic myeloid leukemia responsive to imatinib

enthalten in: American journal of hematology | 2015

von Latagliata, R. | Volpicelli, P. | Breccia, M. | +11

3

The Importance of Body Surface Area at Baseline and during Treatment in Chronic Myeloid Leukemia Patients Treated with Imatinib

enthalten in: Acta haematologica | 2015

von Breccia, M. | Molica, M. | Colafigli, G. | +1

4

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival

enthalten in: Leukemia research | 2014

von Breccia, M. | Luciano, L. | Latagliata, R. | +33

CommentIn: Leuk Res. 2014 Oct;38(10):1156-7. - PMID 25113280

5

Discontinuation of tyrosine kinase inhibitors and new approaches to target leukemic stem cells : treatment-free remission as a new goal in chronic myeloid leukemia

enthalten in: Cancer letters | 2014

von Breccia, M. | Alimena, G.

6

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients : the EORTC QLQ-CML24

enthalten in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation | 2014

von Efficace, F. | Baccarani, M. | Breccia, M. | +19

7

Profiling chronic myeloid leukemia patients reporting intentional and unintentional non-adherence to lifelong therapy with tyrosine kinase inhibitors

enthalten in: Leukemia research | 2014

von Efficace, F. | Rosti, G. | Cottone, F. | +5

8

Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib

enthalten in: Leukemia & lymphoma | 2014

von Breccia, M. | Salaroli, A. | Serrao, A. | +3

9

Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

enthalten in: American journal of hematology | 2014

von Malagola, M. | Breccia, M. | Skert, C. | +29

10

Imatinib induces body mass changes in women with chronic myeloid leukemia

enthalten in: Annals of hematology | 2013

von Breccia, M. | Salaroli, A. | Serrao, A. | +2

1
2
3
4
5
6
7
8
Nächster »
[8]